Management of mycoses in daily practice

Area of Science:

• Dermatology
• Mycology
• Pharmacology

Background:

• Clinical guidelines for superficial mycoses are not always practical for daily use.
• Superficial fungal infections exhibit significant heterogeneity, necessitating individualized treatment strategies.
• Accurate diagnosis through microscopic examination and culture is essential for all cases.

Purpose of the Study:

• To outline practical management strategies for various superficial mycoses.
• To highlight the importance of diagnostic confirmation and tailored therapeutic approaches.
• To discuss the role of oral and topical antifungal agents in treating fungal infections.

Main Methods:

• Review of clinically relevant literature data.
• Analysis of treatment protocols for specific superficial mycoses like tinea capitis, corporis, pedis, and onychomycosis.
• Evaluation of oral antifungal agents including fluconazole, itraconazole, and terbinafine.
• Consideration of pharmacological history and potential drug interactions.

Main Results:

• Tinea capitis requires a minimum of six weeks of oral therapy until mycological healing.
• Tinea corporis, cruris, or pedis may necessitate combination therapy (oral and topical).
• Onychomycosis confined to one nail may be treated topically for 6-12 months; extensive or recurrent cases require oral therapy.
• Oral fluconazole is effective for pityriasis versicolor and is a first-line treatment for chronic vulvovaginal candidiasis with a specific dosing regimen.

Conclusions:

• Effective management of superficial mycoses hinges on accurate diagnosis and personalized treatment plans.
• Oral antifungals like fluconazole, itraconazole, and terbinafine are key therapeutic options.
• Patient history, particularly regarding drug interactions, is vital for safe and effective antifungal therapy.